Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Chemours Q4 Adj EPS $0.31 Beats $0.25 Estimate, Sales $1.36B Beat $1.32B Estimate

Author: Benzinga Newsdesk | March 27, 2024 05:33pm

Chemours (NYSE:CC) reported quarterly Adj earnings of $0.31 per share which beat the analyst consensus estimate of $0.25 by 24 percent. The company reported quarterly sales of $1.36 billion which beat the analyst consensus estimate of $1.32 billion by 3.11 percent. This is a 1.72 percent increase over sales of $1.34 billion the same period last year.

Posted In: CC


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist